Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Azilsartan Medoxomil 80 mg vs EDARBI in Healthy Thai Volunteers (Fasting)
TCTR20240703003Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of azilsartan medoxomil in hypertension (HTN) (2 arms), sponsored by International Bio Service. Primary endpoint: Bioequivalence based on pharmacokinetic parameters. Status: unknown.
02
Drugs
azilsartan medoxomil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20240703003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240703003.